Role of Helicobacter pylori in gastric carcinogenesis: The origin of gastric cancers and heterotopic proliferative glands in mongolian gerbils

Helicobacter

Volumn 10, Issue 2, 2005, Pages 97-106

  Tatematsu, Masae ^a   Tsukamoto, Tetsuya ^a   Mizoshita, Tsutomu ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CHROMOGRANIN A;

ANIMAL MODEL; ECTOPIC STOMACH MUCOSA; ENDOCRINE CELL; ERADICATION THERAPY; GASTRITIS; GERBIL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SALT INTAKE; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH GLAND;

ADENOCARCINOMA; ANIMALS; COCARCINOGENESIS; DISEASE MODELS, ANIMAL; GERBILLINAE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METHYLNITRONITROSOGUANIDINE; METHYLNITROSOUREA; PRECANCEROUS CONDITIONS; SODIUM CHLORIDE, DIETARY; STEM CELLS; STOMACH NEOPLASMS;

ANIMALIA; BACTERIA (MICROORGANISMS); GERBILLINAE; HELICOBACTER PYLORI; MERIONES UNGUICULATUS;

EID: 16444383089     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2005.00305.x     Document Type: Review

References (99)

1. Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;i:1273-5.
2. Marshall Bjaw JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984:1311-5.
3. Hu PJ, Li YY, Zhou MH, Chen MH, Du GG, Huang BJ, Mitchell HM, Hazell SL. Helicobacter pylori associated with a high prevalence of duodenal ulcer disease and a low prevalence of gastric cancer in a developing nation. Gut 1995;36:198-202.
4. Craanen ME, Dekker W, Blok P, Ferwerda J, Tytgat GN. Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut 1992;33:16-20.
5. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
6. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325:1132-6.
7. Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey AR, Wald N, Sitas F. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Bmj 1991;302:1302-5.
8. Graham DY, Lew GM, Klein PD, Evans DG, Evans DJ Jr., Saeed ZA, Malaty HM. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992;116:705-8.
9. Kuipers EJ, Uyterlinde AM, Pena AS, Roosendaal R, Pals G, Nelis GF, Festen HP, Meuwissen SG. Long-term sequelae of Helicobactern pylori gastritis. Lancet 1995;345:1525-8.
10. Asaka M, Kato M, Kudo M, Katagiri M, Nishikawa K, Koshiyama H, Takeda H, Yoshida J, Graham DY. Atrophic changes of gastric mucosa are caused by Helicobacter pylori infection rather than aging: studies in asymptomatic Japanese adults. Helicobacter 1996;1:52-6.
11. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114:1169-79.
12. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Friedman GD. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330:1267-71.
13. Group TES. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993;341:1359-62.
14. Iarc L. 'Schistosomes, liver flukes and Helicobacter pylori', IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 1994;61:1-241.
15. Krakowka S, Morgan DR, Kraft WG, Leunk RD. Establishment of gastric Campylobacter pylori infection in the neonatal gnotobiotic piglet. Infect Immun 1987;55:2789-96.
16. Radin MJ, Eaton KA, Krakowka S, Morgan DR, Lee A, Otto G, Fox J. Helicobacter pylori gastric infection in gnotobiotic beagle dogs. Infect Immun 1990;58:2606-12.
17. Lee A, Fox JG, Otto G, Murphy J. A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterology 1990;99:1315-23.
18. Karita M, Kouchiyama T, Okita K, Nakazawa T. New small animal model for human gastric Helicobacter pylori infection: success in both nude and euthymic mice. Am J Gastroenterol 1991;86:1596-603.
19. Karita M, Li Q, Cantero D, Okita K. Establishment of a small animal model for human Helicobacter pylori infection using germ-free mouse. Am J Gastroenterol 1994;89:208-13.
20. Marchetti M, Arico B, Burroni D, Figura N, Rappuoli R, Ghiara P. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 1995;267:1655-8.
21. Fox JG, Li X, Cahill RJ, Andrutis K, Rustgi AK, Odze R, Wang TC. Hypertrophic gastropathy in Helicobacter felis-infected wild-type C57BL/6 mice and p53 hemizygous transgenic mice. Gastroenterology 1996;110:155-66.
22. Hirayama F, Takagi S, Yokoyama Y, Iwao E, Ikeda Y. Establishment of gastric Helicobacter pylori infection in Mongolian gerbils. J Gastroenterol 1996;31:24-8.
23. Tatematsu M, Yamamoto M, Shimizu N, Yoshikawa A, Fukami H, Kaminishi M, Oohara T, Sugiyama A, Ikeno T. Induction of glandular stomach cancers in Helicobacter pylori-sensitive Mongolian gerbils treated with N-methyl-N′-nitrosourea and N-methyl-N′-nitro-N-nitrosoguanidine in drinking water. Jpn J Cancer Res 1998;89:97-104.
24. Sugiyama A, Maruta F, Ikeno T, Ishida K, Kawasaki S, Katsuyama T, Shimizu N, Tatematsu M. Helicobacter pylori infection enhances N-methyl-N-nitrosourea- induced stomach carcinogenesis in the Mongolian gerbil. Cancer Res 1998;58:2067-9.
25. Shimizu N, Inada K, Nakanishi H, Tsukamoto T, Ikehara Y, Kaminishi M, Kuramoto S, Sugiyama A, Katsuyama T, Tatematsu M. Helicobacter pylori infection enhances glandular stomach carcinogenesis in Mongolian gerbils treated with chemical carcinogens. Carcinogenesis 1999;20:669-76.
26. Shimizu N, Inada KI, Tsukamoto T, Nakanishi H, Ikehara Y, Yoshikawa A, Kaminishi M, Kuramoto S, Tatematsu M. New animal model of glandular stomach carcinogenesis in Mongolian gerbils infected with Helicobacter pylori and treated with a chemical carcinogen. J Gastroenterol 1999;34:61-6.
27. Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, Miki K, Graham DY. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992;102:760-6.
28. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
29. You WC, Zhang L, Gail MH, et al. Gastric dysplasia and gastric cancer. Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst 2000;92:1607-12.
30. Shimizu N, Ikehara Y, Inada K, et al. Eradication diminishes enhancing effects of Helicobacter pylori infection on glandular stomach carcinogenesis in Mongolian gerbils. Cancer Res 2000;60:1512-4.
31. Cao X, Tsukamoto T, Nozaki K, Tanaka H, Shimizu N, Kaminishi M, Kumagai T, Tatematsu M. Earlier Helicobacter pylori infection increases the risk for the N-Methyl-N-nitrosourea-induced stomach carcinogenesis in Mongolian gerbils. Jpn J Cancer Res 2002;93:1293-8.
32. Malaty HM, El-Kasabany A, Graham DY, Miller CC, Reddy SG, Srinivasan SR, Yamaoka Y, Berenson GS. Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet 2002;359:931-5.
33. Correa P, Fontham ET, Bravo JC, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst 2000;92:1881-8.
34. Tajima K, Tominaga S. Dietary habits and gastro-intestinal cancers: a comparative case-control study of stomach and large intestinal cancers in Nagoya, Japan. Jpn J Cancer Res 1985;76:705-16.
35. Tsugane S, Tsuda M, Gey F, Watanabe S. Cross-sectional study with multiple measurements of biological markers for assessing stomach cancer risks at the population level. Environ Health Perspect 1992;98:207-10.
36. Joossens JV, Hill MJ, Elliott P, Stamler R, Lesaffre E, Dyer A, Nichols R, Kesteloot H. Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group. Int J Epidemiol 1996;25:494-504.
37. Kono S, Hirohata T. Nutrition and stomach cancer. Cancer Causes Control 1996;7:41-55.
38. Tatematsu M, Takahashi M, Fukushima S, Hananouchi M, Shirai T. Effects in rats of sodium chloride on experimental gastric cancers induced by N-methyl-N-nitro-N-nitrosoguanidine or 4-nitroquinoline-1-oxide. J Natl Cancer Inst 1975;55:101-6.
39. Takahashi M, Nishikawa A, Furukawa F, Enami T, Hasegawa T, Hayashi Y. Dose-dependent promoting effects of sodium chloride (NaCl) on rat glandular stomach carcinogenesis initiated with N-methyl-N′-nitro-N- nitrosoguanidine. Carcinogenesis 1994;15:1429-32.
40. Furihata C, Ohta H, Katsuyama T. Cause and effect between concentration-dependent tissue damage and temporary cell proliferation in rat stomach mucosa by NaCl, a stomach tumor promoter. Carcinogenesis 1996;17:401-6.
41. Nozaki K, Shimizu N, Inada K, Tsukamoto T, Inoue M, Kumagai T, Sugiyama A, Mizoshita T, Kaminishi M, Tatematsu M. Synergistic promoting effects of Helicobacter pylori infection and high-salt diet on gastric carcinogenesis in Mongolian gerbils. Jpn J Cancer Res 2002;93:1083-9.
42. Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K, Sasaki N, Haruma K, Sumii K, Kajiyama G. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997;6:639-42.
43. Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. Jama 2004;291:187-94.
44. Nozaki K, Shimizu N, Ikehara Y, Inoue M, Tsukamoto T, Inada K, Tanaka H, Kumagai T, Kaminishi M, Tatematsu M. Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils. Cancer Sci 2003;94:235-9.
45. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;112:1442-7.
46. Naef AP, Savary M, Ozzello L. Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas. J Thorac Cardiovasc Surg 1975;70:826-35.
47. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 1998;115:642-8.
48. Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 1998;58:4255-9.
49. Hirayama F, Takagi S, Iwao E, Yokoyama Y, Haga K, Hanada S. Development of poorly differentiated adenocarcinoma and carcinoid due to long-term Helicobacter pylori colonization in Mongolian gerbils. J Gastroenterol 1999;34:450-4.
50. Nozaki K, Shimizu N, Tsukamoto T, Inada K, Cao X, Ikehara Y, Kaminishi M, Sugiyama A, Tatematsu M. Reversibility of heterotopic proliferative glands in glandular stomach of Helicobacter pylori-infected Mongolian gerbils on eradication. Jpn J Cancer Res 2002;93:374-81.
51. Tsukamoto T, Nozaki K, Tatematsu M. Mechanism of Helicobacter pylori induced stomach carcinogenesis - analysis using animal models. Nippon Rinsho 2003;61:56-60.
52. Cao X, Tsukamoto T, Nozaki K, Shimizu N, Mizoshita T, Kumagai T, Kaminishi M, Tatematsu M. Eradication of Helicobacter pylori induces apoptosis and inhibits proliferation of heterotopic proliferative glands in infected Mongolian gerbils. Cancer Sci 2004;95:872-7.
53. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
54. Nakamura K, Sugano H, Takagi K. Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. Gann 1968;59:251-8.
55. Sugano H, Nakamura K, Kato Y. Pathological studies of human gastric cancer. Acta Pathol Jpn 1982;32:329-47.
56. Tatematsu M, Tsukamoto T, Inada K. Stem cells and gastric cancer - role of gastric and intestinal mixed intestinal metaplasia. Cancer Sci 2003;94:135-41.
57. Yoshikawa A, Inada Ki K, Yamachika T, Shimizu N, Kaminishi M, Tatematsu M. Phenotypic shift: in human differentiated gastric cancers from gastric to intestinal epithelial cell type during disease progression. Gastric Cancer 1998;1:134-41.
58. Egashira Y, Shimoda T, Ikegami M. Mucin histochemical analysis of minute gastric differentiated adenocarcinoma. Pathol Int 1999;49:55-61.
59. Koseki K, Takizawa T, Koike M, Ito M, Nihei Z, Sugihara K. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer 2000;89:724-32.
60. Tajima Y, Shimoda T, Nakanishi Y, Yokoyama N, Tanaka T, Shimizu K, Saito T, Kawamura M, Kusano M, Kumagai K. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions. Oncology 2001;61:212-20.
61. Kawachi H, Takizawa T, Eishi Y, Shimizu S, Kumagai J, Funata N, Koike M. Absence of either gastric or intestinal phenotype in microscopic differentiated gastric carcinomas. J Pathol 2003;199:436-46.
62. Mizoshita T, Inada K, Tsukamoto T, Nozaki K, Joh T, Itoh M, Yamamura Y, Ushijima T, Nakamura S, Tatematsu M. Expression of the intestine-specific transcription factors, Cdx1 and Cdx2, correlates shift to an intestinal phenotype in gastric cancer cells. J Cancer Res Clin Oncol 2004;130:29-36.
63. Mizoshita T, Tsukamoto T, Nakanishi H, Inada K, Ogasawara N, Joh T, Itoh M, Yamamuri Y, Tatematsu M. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis. J Cancer Res Clin Oncol 2003;129:727-34.
64. Mizoshita T, Tsukamoto T, Inada K, Ogasawara N, Hirata A, Kato S, Joh T, Itoh M, Yamamura Y, Tatematsu M. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa. Pathol Int 2004;54:392-400.
65. Tatematsu M, Ichinose M, Miki K, Hasegawa R, Kato T, Ito N. Gastric and intestinal phenotypic expression of human stomach cancers as revealed by pepsinogen immunohistochemistry and mucin histochemistry. Acta Pathol Jpn 1990;40:494-504.
66. Inada K, Nakanishi H, Fujimitsu Y, Shimizu N, Ichinose M, Miki K, Nakamura S, Tatematsu M. Gastric and intestinal mixed and solely intestinal types of intestinal metaplasia in the human stomach. Pathol Int 1997;47:831-41.
67. Tsukamoto T, Inada K, Tanaka H, Mizoshita T, Mihara M, Ushijima T, Yamamura Y, Nakamura S, Tatematsu M. Down regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia. J Cancer Res Clin Oncol 2004;130:135-45.
68. Tsukamoto T, Mizoshita T, Mihara M, Tanaka H, Takenaka Y, Yamamura Y, Nakamura S, Ushijima T, Tatematsu M. Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes. Histopathology in press.
69. Mizoshita T, Inada K, Tsukamoto T, Kodera Y, Yamamura Y, Hirai T, Kato T, Joh T, Itoh M, Tatematsu M. Expression of Cdx1 and Cdx2 mRNAs and relevance of this expression to differentiation in human gastrointestinal mucosa - with special emphasis on participation in intestinal metaplasia of the human stomach. Gastric Cancer 2001;4:185-91.
70. Li XL, Eishi Y, Bai YQ, Sakai H, Akiyama Y, Tani M, Takizawa T, Koike M, Yuasa Y. Expression of the SRY-related Mongolian gerbils box protein SOX2 in human gastric carcinoma. Int J Oncol 2004;24:257-63.
71. Almeida R, Suva E, Santos-Silva F, Silberg DG, Wang J, De Bolos C, David L. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J Pathol 2003;199:36-40.
72. Yuasa H, Inada K, Watanabe H, Tatematsu M. A phenotypic shift from gastric-intestinal to solely intestinal cell types in intestinal metaplasia in rat stomach following treatment with X-rays. J Toxicol Pathol 2002;15:85-93.
73. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988;48:3554-60.
74. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995;19:S37-43.
75. Stemmermann GN, Hayashi T. Intestinal metaplasia of the gastric mucosa: a gross and microscopic study of its distribution in various disease states. J Natl Cancer Inst 1968;41:627-34.
76. Morson BC. Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa. Br J Cancer 1955;9:377-85.
77. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735-40.
78. You WC, Blot WJ, Li JY, et al. Precancerous gastric lesions in a population at high risk of stomach cancer. Cancer Res 1993;53:1317-21.
79. Yuasa Y. Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer 2003;3:592-600.
80. Tatematsu M, Katsuyama T, Furihata C, Tsuda H, Ito N. Stable intestinal phenotypic expression of gastric and small intestinal tumor cells induced by N-methyl-N′-nitro-N-nitrosoguanidine or methylnitrosourea in rats. Gann 1984;75:957-65.
81. Tatematsu M, Furihata C, Katsuyama T, Hasegawa R, Nakanowatari J, Saito D, Takahashi M, Matsushima T, Ito N. Independent induction of intestinal metaplasia and gastric cancer in rats treated with N-methyl-N′-nitro-N- nitrosoguanidine. Cancer Res 1983;43:1335-41.
82. Tatematsu M, Furihata C, Katsuyama T, Miki K, Honda H, Konishi Y, Ito N. Gastric and intestinal phenotypic expressions of human signet ring cell carcinomas revealed by their biochemistry, mucin histochemistry, and ultrastructure. Cancer Res 1986;46:4866-72.
83. Hattori T. Development of adenocarcinomas in the stomach. Cancer 1986;57:1528-34.
84. Kushima R, Hattori T. Histogenesis and characteristics of gastric-type adenocarcinomas in the stomach. J Cancer Res Clin Oncol 1993;120:103-11.
85. Saito A, Shimoda T, Nakanishi Y, Ochiai A, Toda G. Histologic heterogeneity and mucin phenotypic expression in early gastric cancer. Pathol Int 2001;51:165-71.
86. Tatematsu M, Katsuyama T, Fukushima S, Takahashi M, Shirai T, Ito N, Nasu T. Mucin histochemistry by paradoxical concanavalin A staining in experimental gastric cancers induced in Wistar rats by N-methyl-N-nitro-N-nitrosoguanidine or 4-nitroquinoline 1-oxide. J Natl Cancer Inst 1980b;64:835-43.
87. Tatematsu M, Katsuyama T, Furihata C, Fukushima S, Shirai T, Kato T, Ito N. Cellular differentiation and histogenesis of rat glandular stomach cancers. Jpn J Cancer Res 1990;81:760-7.
88. Yamachika T, Inada K, Fujimitsu Y, Nakamura S, Yamamura Y, Kitou T, Itzkowitz SH, Werther JL, Miki K, Tatematsu M. Intestinalization of gastric signet ring cell carcinomas with progression. Virchows Arch 1997;431:103-10.
89. Bamba M, Sugihara H, Kushima R, Okada K, Tsukashita S, Horinouchi M, Hattori T. Time-dependent expression of intestinal phenotype in signet ring cell carcinomas of the human stomach. Virchows Arch 2001;438:49-56.
90. Tamura G, Sakata K, Maesawa C, Suzuki Y, Terashima M, Satoh K, Sekiyama S, Suzuki A, Eda Y, Satodate R. Microsatellite alterations in adenoma and differentiated adenocarcinoma of the stomach. Cancer Res 1995;55:1933-6.
91. Endoh Y, Sakata K, Tamura G, Ohmura K, Ajioka Y, Watanabe H, Motoyama T. Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways. J Pathol 2000;191:257-63.
92. Matsukuma A, Mori M, Enjoji M. Sulphomucin-secreting intestinal metaplasia in the human gastric mucosa. An association with intestinal-type gastric carcinoma. Cancer 1990;66:689-94.
93. Kusakabe M, Yokoyama M, Sakakura T, Nomura T, Hosick HL, Nishizuka Y. A novel methodology for analysis of cell distribution in chimeric mouse organs using a strain specific antibody. J Cell Biol 1988;107:257-65.
94. Lee GH, Nomura K, Kanda H, Kusakabe M, Yoshiki A, Sakakura T, Kitagawa T. Strain-specific sensitivity to diethylnitrosamine-induced carcinogenesis is maintained in hepatocytes of C3H/HeN in equilibrium with C57BL/6N chimeric mice. Cancer Res 1991;51:3257-60.
95. Tsukamoto T, Inada K, Fukami H, Yamamoto M, Tanaka H, Kusakabe M, Bishop CE, Tatematsu M. Mouse strain susceptibility to diethylnitrosamine induced hepatocarcinogenesis is cell autonomous whereas sex-susceptibility Is due to the micro-environment: analysis with C3H↔ BALB/c sexually chimeric mice. Jpn J Cancer Res 2000;91:665-73.
96. Tatematsu M, Fukami H, Yamamoto M, Nakanishi H, Masui T, Kusakabe N, Sakakura T. Clonal analysis of glandular stomach carcinogenesis in C3H/HeN↔BALB/c chimeric mice treated with N-methyl-N-nitrosourea. Cancer Lett 1994;83:37-42.
97. Tatematsu M, Masui T, Fukami H, Yamamoto M, Nakanishi H, Inada K, Kusakabe M, Sakakura T. Primary monoclonal and secondary polyclonal growth of colon neoplastic lesions in C3H/ HeN↔BALB/c chimeric mice treated with 1,2-dimethylhydrazine immunohistochemical detection of C3H strain-specific antigen and simple sequence length polymorphism analysis of DNA. Int J Cancer 1996;66:234-8.
98. Tatematsu M, Ogawa K, Hoshiya T, Shichina Y, Kato T, Imaida K, Ito N. Induction of adenocarcinomas in the glandular stomach of BALB/c mice treated with N-methyl-N-nitrosourea. Jpn J Cancer Res 1992;83:915-8.
99. Tatematsu M, Yamamoto M, Iwata H, Fukami H, Yuasa H, Tezuka N, Masui T, Nakanishi H. Induction of glandular stomach cancers in C3H mice treated with N-methyl-N-nitrosourea in the drinking water. Jpn J Cancer Res 1993a;84:1258-64.